Recommendations for the use of cardiac troponin measurement in acute cardiac care.
暂无分享,去创建一个
Mario Plebani | Joseph S Alpert | Evangelos Giannitsis | Kristian Thygesen | Marco Tubaro | Wolfgang Koenig | J. Alpert | A. Jaffe | P. Collinson | W. Koenig | K. Huber | Y. Hasin | B. Lindahl | K. Thygesen | J. Mair | H. Katus | P. Venge | E. Giannitsis | C. Hamm | M. Galvani | M. Tubaro | M. Plebani | Bertil Lindahl | Per Venge | Christian Hamm | C. Mueller | Allan S Jaffe | Kurt Huber | Paul Collinson | Christian Mueller | Marcello Galvani | Johannes Mair | Hugo Katus | Luigi M Biasucci | Yonathan Hasin | L. Biasucci | C. Mueller
[1] A. Jaffe,et al. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.
[2] A. Jaffe,et al. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. , 2010, Clinical chemistry.
[3] A. Jaffe,et al. Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.
[4] Michael Marber,et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .
[5] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.
[6] B. Lindahl,et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. , 2009, Journal of the American College of Cardiology.
[7] M. Adamczyk,et al. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. , 2009, Clinical chemistry.
[8] Fred S Apple,et al. A new season for cardiac troponin assays: it's time to keep a scorecard. , 2009, Clinical chemistry.
[9] Callum G Fraser,et al. Reference change values: the way forward in monitoring , 2009, Annals of clinical biochemistry.
[10] A. Jaffe,et al. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. , 2009, Clinical chemistry.
[11] M. Sabatine,et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.
[12] A. Wu,et al. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. , 2009, Clinical chemistry.
[13] A. Jaffe,et al. Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. , 2009, Clinical chemistry.
[14] M. Panteghini. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins , 2009, Clinical chemistry and laboratory medicine.
[15] Lars Lind,et al. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. , 2009, Clinical chemistry.
[16] E. Antman,et al. Evaluation of high-sensitivity assays for cardiac troponin. , 2009, Clinical chemistry.
[17] J. Tate. Troponin revisited 2008: assay performance , 2008, Clinical chemistry and laboratory medicine.
[18] D. Atsma,et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. , 2008, Experimental and molecular pathology.
[19] E. Barrett-Connor,et al. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. , 2008, Journal of the American College of Cardiology.
[20] H. Katus,et al. Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. , 2008, Clinical chemistry.
[21] W. Markiewicz,et al. Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes. , 2008, The American journal of cardiology.
[22] K. Kostner,et al. The determination of the 99th centile level for troponin assays in an Australian reference population , 2008, Annals of clinical biochemistry.
[23] Bekele Afessa,et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients , 2008, Critical care medicine.
[24] A. Jaffe,et al. Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. , 2008, Clinical chemistry.
[25] J. Ottervanger,et al. Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[26] A. Jaffe,et al. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. , 2008, American heart journal.
[27] A. Jaffe,et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.
[28] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[29] M. Panteghini,et al. Standardization of troponin I measurements: an update , 2008, Clinical chemistry and laboratory medicine.
[30] Jeroen J. Bax,et al. Universal definition of myocardial infarction. , 2007 .
[31] A. Jaffe,et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. , 2007, The American journal of cardiology.
[32] D. Morrow,et al. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. , 2007, American journal of clinical pathology.
[33] G. Agnelli,et al. Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis , 2007, Circulation.
[34] Susan R. Wilson,et al. Reporting of cardiac troponin - problems with the 99th population percentile. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[35] Matthew W. Martinez,et al. Myocardial infarction with normal coronary arteries: a role for MRI? , 2007, Clinical chemistry.
[36] D. Pennell,et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.
[37] A. Jaffe,et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. , 2007, Clinical chemistry.
[38] Fred S Apple,et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. , 2007, Circulation.
[39] Robert H Christenson,et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Clinical chemistry.
[40] A. Jaffe,et al. Long-term health outcomes associated with detectable troponin I concentrations. , 2007, Clinical chemistry.
[41] M. Cubizolles,et al. SELDI‐TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction , 2006, Proteomics.
[42] N. Curzen,et al. Troponin-positive chest pain with unobstructed coronary arteries: a role for delayed enhanced cardiovascular magnetic resonance in the diagnosis of non-ST elevation myocardial infarction. , 2006, The Journal of invasive cardiology.
[43] A. Wu,et al. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. , 2006, Clinical chemistry.
[44] M. Welch,et al. Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. , 2006, Clinical chemistry.
[45] N. Blanckaert,et al. Can heparin plasma be used instead of serum for nephelometric analysis of serum proteins? , 2006, Clinical chemistry.
[46] A. Jaffe,et al. Importance of low concentrations of cardiac troponins. , 2006, Clinical chemistry.
[47] A. Jaffe,et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. , 2006, Clinical chemistry.
[48] A. Khera,et al. Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.
[49] A. Wu,et al. Influence of imprecision on ROC curve analysis for cardiac markers. , 2006, Clinical chemistry.
[50] J. Christiansen,et al. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. , 2006, The American journal of cardiology.
[51] BjörnZethelius,et al. Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men , 2006 .
[52] P. Venge,et al. Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study , 2006, Circulation.
[53] David M Bunk,et al. Characterization of a new certified reference material for human cardiac troponin I. , 2006, Clinical chemistry.
[54] P. Collinson,et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T , 2005, Heart.
[55] W. Wodzig,et al. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography , 2006, Clinical chemistry and laboratory medicine.
[56] A. Levin,et al. Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis , 2005, Circulation.
[57] A. Jaffe,et al. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. , 2005, Clinical chemistry.
[58] P. Porela,et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. , 2005, Clinical chemistry.
[59] K. Pulkki,et al. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. , 2005, Clinical chemistry.
[60] Stuart D Katz,et al. Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure , 2005, Circulation.
[61] M. Parmacek,et al. Biology of the troponin complex in cardiac myocytes. , 2004, Progress in cardiovascular diseases.
[62] B. Lindahl,et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. , 2004, American heart journal.
[63] J. Phillips,et al. The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[64] Charles Weissman,et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. , 2003, Journal of the American College of Cardiology.
[65] Fred S Apple,et al. Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease , 2002, Circulation.
[66] C. Cannon,et al. Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy , 2002, Circulation.
[67] G. Cembrowski,et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. , 2002, Clinical chemistry.
[68] A. Wu,et al. Multicenter evaluation of an automated assay for troponin I. , 2002, Clinical chemistry.
[69] A. Go,et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. , 2001, Journal of the American College of Cardiology.
[70] J. Canty,et al. Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.
[71] A. Wu,et al. Quality Specifications for Cardiac Troponin Assays , 2001, Clinical chemistry and laboratory medicine.
[72] B. Bluestein,et al. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. , 2000, Circulation.
[73] A. Jaffe,et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. , 2000, American heart journal.
[74] H. Katus,et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. , 2000, Clinical chemistry.
[75] F. Apple,et al. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. , 1999, Clinical chemistry.
[76] F. Apple,et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. , 1998, Clinical chemistry.
[77] A. Wu,et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. , 1998, Clinical chemistry.
[78] K. Pulkki,et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. , 1997, Clinical chemistry.
[79] A. Remppis,et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. , 1995, Journal of molecular and cellular cardiology.
[80] A. Jaffe,et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. , 1994, Clinical chemistry.
[81] A. Remppis,et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. , 1992, Clinical chemistry.